Incidence and mortality from prostate cancer were rising in most countries until the late
1980s. Following a number of advances in the management of prostate cancer, including …

Prostate cancer screening has become very prevalent in most countries around the world
since the early 1990's. A national interview study in the United States has reported 75% and …

The first phase of the Flint Men's Health Study (FMHS) in Michigan was a community-based
epidemiologic study of prostate cancer and benign prostatic hyperplasia (BPH) in African …

ContextDespite widespread use of serum prostate-specific antigen (PSA) testing to detect
prostate cancer, the relative effectiveness of different PSA screening strategies is unknown …

Importance Black men have higher prostate cancer incidence and mortality than non-
Hispanic White men. However, Black men have been underrepresented in clinical trials of …

This paper presents prostate cancer incidence and mortality rates in the United States by
factors associated with the disease at diagnosis and explores racial differences in these …

Objective To investigate whether prostate cancer screening with prostate-specific antigen
(PSA) is beneficial in reducing prostate cancer mortality, and to determine optimal screening …

Changes in prostate cancer detection and patterns of care may account for recent declines
in prostate cancer mortality in the United States.

Abstract In the United States, prostate cancer is the most commonly diagnosed non–skin
cancer and the second leading cause of cancer death. The American Cancer Society …

The incidence and mortality of prostate cancer is highly varied among populations and
especially among blacks and whites. The incidence rates of all American populations have …